Robert M. Gervis, Director at ASPEN AEROGELS INC (ASPN), bought 100 shares at $3.98 ($398) on 2017-03-27, disclosed to the SEC on 2017-03-28.
Scheduled purchase ($398) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ASPN | BUY | 2017-05-08 | $3K | — | Filing → |
| ASPN | BUY | 2017-05-04 | $2K | — | Filing → |
| ASPN | BUY | 2017-05-02 | $1K | — | Filing → |